Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.

Boniface, Karen; Byars, Sean G; Cowley, Daniel; Kirkwood, Carl D; Bines, Julie E

Boniface, Karen; Byars, Sean G; Cowley, Daniel; Kirkwood, Carl D; Bines, Julie E.

Affiliation

Boniface K; Enteric Diseases Group, Murdoch Children's Research Institute, Seattle, Washington.
Byars SG; Melbourne School of Population and Global Health, Seattle, Washington.
Cowley D; Enteric Diseases Group, Murdoch Children's Research Institute, Seattle, Washington.
Kirkwood CD; Department of Pediatrics, University of Melbourne, Seattle, Washington.
Bines JE; Enteric Diseases Group, Murdoch Children's Research Institute, Seattle, Washington.

J Infect Dis ; 221(7): 1070-1078, 2020 03 16.

Article in En | MEDLINE | ID: mdl-31763671

Subject(s)

Blood Group Antigens; Rotavirus Vaccines/administration & dosage; Rotavirus Vaccines/immunology; Antibodies, Viral/blood; Cohort Studies; Feces/enzymology; Fucosyltransferases/genetics; Humans; Infant, Newborn; Galactoside 2-alpha-L-fucosyltransferase

Key words

Lewis antibodies; RV3-BB; Rotavirus; histo-blood group antigens; neonatal vaccination; secretor status; vaccine take

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Group Antigens / Rotavirus Vaccines Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans / Newborn Language: En Journal: J Infect Dis Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google